Antidepressants to Strengthen US Generics Market
As per our new research report, “Booming US Generic Drug Market”, the US generics market has witnessed stupendous growth in recent times driven mainly by patent expiration of key blockbuster drugs. As both consumers and the governments are trying to reduce healthcare costs, the country is experiencing a renowned focus on generics by both the entities. In 2009, the US generic drugs sector was valued at US$ 74 Billion, and is likely to grow further at a CAGR of around...
View full press release